These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 21475844)

  • 1. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Glas M; Hundsberger T; Stuplich M; Wiewrodt D; Kurzwelly D; Nguyen-Huu B; Rasch K; Herrlinger U
    Oncology; 2009; 76(3):184-9. PubMed ID: 19218824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma.
    Fujimaki T; Ishii H; Matsuno A; Arai H; Nakagomi T
    World J Surg Oncol; 2007 Aug; 5():89. PubMed ID: 17683572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rechallenge with temozolomide with different scheduling is effective in recurrent malignant gliomas.
    Strik HM; Buhk JH; Wrede A; Hoffmann AL; Bock HC; Christmann M; Kaina B
    Mol Med Rep; 2008; 1(6):863-7. PubMed ID: 21479498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide salvage chemotherapy for recurrent anaplastic oligodendroglioma and oligo-astrocytoma.
    Gwak HS; Yee GT; Park CK; Kim JW; Hong YK; Kang SG; Kim JH; Seol HJ; Jung TY; Chang JH; Yoo H; Hwang JH; Kim SH; Park BJ; Hwang SC; Kim MS; Kim SH; Kim EY; Kim E; Kim HY; Ko YC; Yun HJ; Youn JH; Kim J; Lee B; Lee SH
    J Korean Neurosurg Soc; 2013 Dec; 54(6):489-95. PubMed ID: 24527191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade gliomas.
    Theeler BJ; Groves MD
    Curr Treat Options Neurol; 2011 Aug; 13(4):386-99. PubMed ID: 21499746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief report: pediatric high-grade gliomas treated with vinorelbine and valproic acid added to temozolomide.
    Guidi M; Giunti L; Buccoliero AM; Fonte C; Scoccianti S; Censullo ML; Caporalini C; Tellini M; Di Nicola M; Castelli B; Greto D; Giordano F; Genitori L; Sardi I
    Am J Cancer Res; 2023; 13(8):3668-3678. PubMed ID: 37693163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.
    Saito R; Kanamori M; Sonoda Y; Yamashita Y; Nagamatsu K; Murata T; Mugikura S; Kumabe T; Wembacher-Schröder E; Thomson R; Tominaga T
    Neurooncol Adv; 2020; 2(1):vdaa033. PubMed ID: 32642691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ
    Uckun FM; Qazi S; Hwang L; Trieu VN
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31795071
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaplastic astrocytoma cells not detectable on autopsy following long-term temozolomide treatment: A case report.
    Hirano H; Kawahara T; Niiro M; Yonezawa H; Takajyou T; Ohi Y; Kitazono I; Sakae K; Arita K
    Mol Clin Oncol; 2017 Mar; 6(3):321-326. PubMed ID: 28451406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of various dose-dense regimens of temozolomide for recurrent high-grade glioma: a systematic review with meta-analysis.
    Wei W; Chen X; Ma X; Wang D; Guo Z
    J Neurooncol; 2015 Nov; 125(2):339-49. PubMed ID: 26334318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy with temozolomide for recurrent or progressive high-grade gliomas refractory to ACNU [1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride].
    Terasaki M; Tokutomi T; Shigemori M
    Mol Med Rep; 2009; 2(3):417-21. PubMed ID: 21475844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma.
    Terasaki M; Abe T; Miyagi N; Ogo E; Shigemori M
    J Neurooncol; 2007 Feb; 81(3):265-9. PubMed ID: 16937011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated radiotherapy and multi-agent chemotherapy (procarbazine, ACNU and vincristine) for high-grade gliomas: a prospective study.
    Ogawa K; Yoshii Y; Toita T; Saito A; Kakinohana Y; Iraha S; Sugimoto K; Tsuchida Y; Tamaki W; Adachi G; Hyodo A; Murayama S
    Anticancer Res; 2006; 26(3B):2457-62. PubMed ID: 16821632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.